Notch Signaling Plays a Crucial Role in Cancer Stem-like Cells Maintaining Stemness and Mediating Chemotaxis in Renal Cell Carcinoma

Overview

Journal J Exp Clin Cancer Res

Publisher Biomed Central

Specialty Oncology

Date 2017 Mar 11

PMID 28279221

Citations 82

Authors

Wei Xiao

Zhiyong Gao

Yixing Duan

Wuxiong Yuan

Yang Ke

Affiliations

Soon will be listed here.

Abstract

Background: Cancer stem cells (CSCs) are correlated with the initiation, chemoresistance and relapse of tumors. Notch pathway has been reported to function in CSCs maintenance, but whether it is involved in renal cell carcinoma (RCC) CSCs maintaining stemness remain unclear. This study aims to explore the effect of Notch pathway on stemness of CSCs in RCC and the underlying mechanisms.

Methods: The CD133/CD24 cells were isolated from RCC ACHN and Caki-1 cell line using Magnetic-activated cell sorting and identified by Flow cytometry analysis. RT-PCR and immunoblot analyses were used for determining the stemness maker expression. The effect of Notch pathway on function of CSCs was assessed by self-renewal ability, chemosensitivity, invasive and migratory ability tumorigenicity in vivo using soft agar colony formation assay, sphere-forming assay, MTT assay, Transwell assay.

Results: Here, we found that the sorted CD133/CD24cells possessed elevated stemness maker CTR2, BCL-2, MDR1, OCT-4, KLF4, compared with parental cells, as well as enhanced self-renewal ability, stronger resistance to cisplatin and sorafenib, increased invasion and migration, and higher tumorigenesis in vivo, suggesting the CD133/CD24 cells have the stem-like characteristics of CSCs and thus identified as RCC CSCs. Then the enhanced notch1, notch2, Jagged1, Jagged2, DLL1 and DLL4 expression were detected in RCC CSCs and blockage of Notch1 or notch2 using pharmacological inhibitor MRK-003 or its endogenous inhibitor Numb resulted in loss of its stemness features: self-renewal, chemoresistance, invasive and migratory potential, and tumorigenesis in vivo. Moreover, it is confirmed that overexpression of notch1 up-regulated CXCR4 inRCC CSCs and augmented SDF-1-induced chemotaxis in RCC CSCs in vitro, which could be rescued when treatment of CXCR4 inhibitor, suggesting that notch signaling promotes the chemotaxis of RCC CSCs by SDF-1/CXCR4 axis.

Conclusions: Our results provide a new mechanism of RCC CSCs maintaining stemness via notch pathway as well as a potential therapeutic target in human RCC.

Citing Articles

An update on cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer.

Jan A, Sofi S, Jan N, Mir M Future Oncol. 2025; 21(6):715-735.

PMID: 39936282 PMC: 11881842. DOI: 10.1080/14796694.2025.2461443.

Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence.

Tufail M, Jiang C, Li N Mil Med Res. 2025; 12(1):7.

PMID: 39934876 PMC: 11812268. DOI: 10.1186/s40779-025-00595-2.

Tumor-initiating and metastasis-initiating cells of clear-cell renal cell carcinoma.

Pham D, Hsu T J Biomed Sci. 2025; 32(1):17.

PMID: 39920694 PMC: 11806631. DOI: 10.1186/s12929-024-01111-9.

Crosstalk between GLTSCR1-deficient endothelial cells and tumour cells promotes colorectal cancer development by activating the Notch pathway.

Liu L, Han F, Deng M, Han Q, Lai M, Zhang H Cell Death Differ. 2025; .

PMID: 39870803 DOI: 10.1038/s41418-025-01450-6.

The molecular features of lung cancer stem cells in dedifferentiation process-driven epigenetic alterations.

Masciale V, Banchelli F, Grisendi G, Samarelli A, Raineri G, Rossi T J Biol Chem. 2024; 300(12):107994.

PMID: 39547513 PMC: 11714729. DOI: 10.1016/j.jbc.2024.107994.

References

Huang B, Huang Y, Yao Z, Chen X, Guo S, Mao X . Cancer stem cell-like side population cells in clear cell renal cell carcinoma cell line 769P. PLoS One. 2013; 8(7):e68293. PMC: 3708929. DOI: 10.1371/journal.pone.0068293. View

Buchler P, Gazdhar A, Schubert M, Giese N, Reber H, Hines O . The Notch signaling pathway is related to neurovascular progression of pancreatic cancer. Ann Surg. 2005; 242(6):791-800, discussion 800-1. PMC: 1409885. DOI: 10.1097/01.sla.0000189115.94847.f1. View

Zhang Q, Shi J, Yuan F, Wang H, Fu W, Pan J . Higher expression of XPF is a critical factor in intrinsic chemotherapy resistance of human renal cell carcinoma. Int J Cancer. 2016; 139(12):2827-2837. DOI: 10.1002/ijc.30396. View

Xiong B, Ma L, Hu X, Zhang C, Cheng Y . Characterization of side population cells isolated from the colon cancer cell line SW480. Int J Oncol. 2014; 45(3):1175-83. DOI: 10.3892/ijo.2014.2498. View

Gassenmaier M, Chen D, Buchner A, Henkel L, Schiemann M, Mack B . CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis. Stem Cells. 2013; 31(8):1467-76. DOI: 10.1002/stem.1407. View

Fischer A, Schumacher N, Maier M, Sendtner M, Gessler M . The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev. 2004; 18(8):901-11. PMC: 395849. DOI: 10.1101/gad.291004. View

Wu K, Xu L, Zhang L, Lin Z, Hou J . High Jagged1 expression predicts poor outcome in clear cell renal cell carcinoma. Jpn J Clin Oncol. 2010; 41(3):411-6. DOI: 10.1093/jjco/hyq205. View

Nieh S, Jao S, Yang C, Lin Y, Tseng Y, Liu C . Regulation of tumor progression via the Snail-RKIP signaling pathway by nicotine exposure in head and neck squamous cell carcinoma. Head Neck. 2014; 37(12):1712-21. DOI: 10.1002/hed.23820. View

Zimmerer R, Matthiesen P, Kreher F, Kampmann A, Spalthoff S, Jehn P . Putative CD133+ melanoma cancer stem cells induce initial angiogenesis in vivo. Microvasc Res. 2015; 104:46-54. DOI: 10.1016/j.mvr.2015.12.001. View

10.

Fernandez-Valdivia R, Takeuchi H, Samarghandi A, Lopez M, Leonardi J, Haltiwanger R . Regulation of mammalian Notch signaling and embryonic development by the protein O-glucosyltransferase Rumi. Development. 2011; 138(10):1925-34. PMC: 3082299. DOI: 10.1242/dev.060020. View

11.

Schrader A, Lechner O, Templin M, Dittmar K, Machtens S, Mengel M . CXCR4/CXCL12 expression and signalling in kidney cancer. Br J Cancer. 2002; 86(8):1250-6. PMC: 2375348. DOI: 10.1038/sj.bjc.6600221. View

12.

Hasmim M, Bruno S, Azzi S, Gallerne C, Michel J, Chiabotto G . Isolation and characterization of renal cancer stem cells from patient-derived xenografts. Oncotarget. 2015; 7(13):15507-24. PMC: 4941257. DOI: 10.18632/oncotarget.6266. View

13.

Chin A, Lam J, Figlin R, Belldegrun A . Surveillance strategies for renal cell carcinoma patients following nephrectomy. Rev Urol. 2006; 8(1):1-7. PMC: 1471767. View

14.

Sjolund J, Johansson M, Manna S, Norin C, Pietras A, Beckman S . Suppression of renal cell carcinoma growth by inhibition of Notch signaling in vitro and in vivo. J Clin Invest. 2007; 118(1):217-28. PMC: 2129233. DOI: 10.1172/JCI32086. View

15.

Geramizadeh B, Ravanshad M, Rahsaz M . Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma. Indian J Pathol Microbiol. 2008; 51(2):167-71. DOI: 10.4103/0377-4929.41641. View

16.

McAuliffe S, Morgan S, Wyant G, Tran L, Muto K, Chen Y . Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy. Proc Natl Acad Sci U S A. 2012; 109(43):E2939-48. PMC: 3491453. DOI: 10.1073/pnas.1206400109. View

17.

Artavanis-Tsakonas S, Rand M, Lake R . Notch signaling: cell fate control and signal integration in development. Science. 1999; 284(5415):770-6. DOI: 10.1126/science.284.5415.770. View

18.

Wang Z, Chen J, Capobianco A . The Notch signaling pathway in esophageal adenocarcinoma. Cell Mol Biol (Noisy-le-grand). 2015; 61(6):24-32. View

19.

Khan M, Czarnecka A, Helbrecht I, Bartnik E, Lian F, Szczylik C . Current approaches in identification and isolation of human renal cell carcinoma cancer stem cells. Stem Cell Res Ther. 2015; 6:178. PMC: 4574074. DOI: 10.1186/s13287-015-0177-z. View

20.

Giachino C, Boulay J, Ivanek R, Alvarado A, Tostado C, Lugert S . A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes. Cancer Cell. 2015; 28(6):730-742. DOI: 10.1016/j.ccell.2015.10.008. View